Thursday, 20 Feb 2020

You are here

Potential Reasons Why Osteoarthritis Preferentially Affects Women

Researchers from Augusta University have examined exosomes from patients with knee osteoarthritis (OA) to enhance our molecular understanding of the pathogenesis of OA. (Citation source http://buff.ly/2tuDZ3v)

Exosomes play a vital role in cell-to-cell communication. By obtaining samples from OA patient synovial fluid, researchers analyzed the exosomes that carry microRNAs (miRNAs) that regulate gene expression. Their supposition was that molecular profiling of synovial fluid derived exosomal miRNAs may increase the understanding of OA progression.

They found distinct differences in miRNA activity between men and women with OA.  Interesting, in light of the fact that OA is more common in women than men; the reasons for which are unknown.

The synovial fluid of men showed 69 downregulated and 45 upregulated miRNAs, while in women there were 91 downregulated and 53 upregulated miRNAs.

Women were more likely than men to show a deactivation or alteration of miRNAs that are important for estrogen signaling and collagen production.

Thus the loss of estrogen levels during menopausal years may be associated with an increased risk of OA. It has been previously noted that women on hormone replacement therapy have a lower risk of OA.

One potential use of this stems from their efforts showing that blocking estrogen availability in exosomes using aromatase inhibitors may lead to a reduction in miRNAs.

The study also disclosed that one particular miRNA, called MiR-504-3p, was upregulated in both men and women with OA. The significance of this is unknown but may related to cartilage degeneration. 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

JAK Inhibitors Stimulate Osteoblasts

Science Translational Medicine has a report on how the use of Janus kinase (JAK) inhibitors may boost osteoblasts to battle bone erosions in conditions like rheumatoid arthritis (RA).

JAK inhibitors have been shown in clinical trials to retard the development of bone erosions while controlling RA inflammation and other clinical features.

Hormone Therapy for Postmenopausal Women

The NEJM weighs in on the problem of post-menopausal osteoporosis (OP) and tackles the use of hormonal therapy. The decline in estrogen after menopause may increase risks for osteoporosis, cardiovascular disease, and cognitive decline. The use of hormone replacement therapy (HRT) to obviate these issues may be primarily driven by hot flashes in postmenopausal women.1 Who may benefit from hormone therapy among postmenopausal women?

Knee Replacements Last 25 Years

UK registry reports that greater than 80% of total knee replacements can last for 25 years.

The outcomes regarding the duration and durability of knee arthroplasties is sketchy, with many orthopedists projecting a 15 to 20 year survivial. Hence the need for an appraisal of the data.

Should We Screen Younger Postmenopausal Women for Osteoporosis?

Do postmenopausal women, under age 65 years, need a baseline BMD testing? A JAMA Insights review suggests that the absolute risk of fracture is low in this group and that USPSTF guidelines should be considered - that we should be screening women younger than 65 years who are at increased risk of osteoporosis and we should be using a formal risk assessment tool to identify candidates for bone density testing.

Genicular Artery Embolization to Treat Osteoarthritis Knee Pain

A study from the Journal of Vascular and Interventional Radiology has shown that  knee pain secondary to osteoarthritis (OA) may be effectively treated by selective vascular interruption (embolization) showing efficacy and safety in a small pilot trial.